THE TRULICITY 1.5 MG DIARIES

The trial accomplished equally its Major endpoints, with semaglutide 2.four mg demonstrating statistically major and top-quality advancements in liver fibrosis without any worsening of steatohepatitis, in addition to resolution of steatohepatitis without having worsening of liver fibrosis in people with MASH compared to placebo.oneMounjaro can be u